292 related articles for article (PubMed ID: 16701552)
1. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
[TBL] [Abstract][Full Text] [Related]
3. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin.
Ghaffari A; Li Y; Karami A; Ghaffari M; Tredget EE; Ghahary A
J Cell Biochem; 2006 May; 98(2):383-93. PubMed ID: 16440305
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
[TBL] [Abstract][Full Text] [Related]
7. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
8. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 in dentin matrix mineralization.
Satoyoshi M; Kawata A; Koizumi T; Inoue K; Itohara S; Teranaka T; Mikuni-Takagaki Y
J Endod; 2001 Jul; 27(7):462-6. PubMed ID: 11503997
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in the vein wall.
Kowalewski R; Sobolewski K; Wolanska M; Gacko M
Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells.
Mizutani A; Sugiyama I; Kuno E; Matsunaga S; Tsukagoshi N
J Bone Miner Res; 2001 Nov; 16(11):2043-9. PubMed ID: 11697800
[TBL] [Abstract][Full Text] [Related]
13. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
14. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
15. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity.
Sisková Z; Yong VW; Nomden A; van Strien M; Hoekstra D; Baron W
Mol Cell Neurosci; 2009 Nov; 42(3):234-42. PubMed ID: 19607919
[TBL] [Abstract][Full Text] [Related]
18. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions.
Ullmann U; Gilles C; De Rycke M; Van de Velde H; Sermon K; Liebaers I
Mol Hum Reprod; 2008 Mar; 14(3):169-79. PubMed ID: 18263607
[TBL] [Abstract][Full Text] [Related]
19. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Akgül B; Pfefferle R; Marcuzzi GP; Zigrino P; Krieg T; Pfister H; Mauch C
Exp Dermatol; 2006 Jan; 15(1):35-42. PubMed ID: 16364029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
